Tegretol and Tumor associated fever - a phase IV clinical study of FDA data
No or few reports are found.
The phase IV clinical study is created by eHealthMe based on reports from the FDA, and is updated regularly.
Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 700+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.
No or few reports are found.
What is Tegretol?
Tegretol has active ingredients of carbamazepine. It is used in epilepsy. Currently, eHealthMe is studying from 45,133 Tegretol users.
What is Tumor Associated Fever?
Tumor associated fever is found to be associated with 332 drugs and 129 conditions by eHealthMe. Currently, we are studying 796 people who have Tumor associated fever.
Do you take Tegretol and have Tumor associated fever?Check whether Tumor associated fever is associated with a drug or a condition
How to use the study?
You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.
Tegretol side effects by duration, gender and age:
- Tegretol side effects (45,133 reports)
Tumor associated fever treatments and more:
- Tumor associated fever (796 reports)
All the drugs that are associated with Tumor associated fever:
All the conditions that are associated with Tumor associated fever:
How the study uses the data?
The study uses data from the FDA. It is based on carbamazepine (the active ingredients of Tegretol) and Tegretol (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
Who is eHealthMe?
With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 700+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Cephulac and Prednisolone drug interaction - a second ago
- Suboxone and Application Site Pain - 11 seconds ago
- Pantoprazole Sodium and Naftin drug interaction - 12 seconds ago
- Ezetimibe and Desvenlafaxine drug interaction - 12 seconds ago
- Firdapse and White Blood Cell Count Increased - 13 seconds ago
- Seasonale and Drug Hypersensitivity - 15 seconds ago
- Vincristine Sulfate and Sulfasalazine drug interaction - 17 seconds ago
- Atarax and Paroxysmal Supraventricular Tachycardia - 20 seconds ago
- Lenalidomide and Alendronate Sodium drug interaction - 28 seconds ago
- Dyazide and Methylin drug interaction - 29 seconds ago